Equipment Acquisition and Remarketing

BridgePath Scientific offers Equipment Acquisition and Remarketing

Clients in the News

Clients in the News – Washington Univ. Shows Zika Virus Kills Brain Cancer Stem Cells

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the virus kills brain […]

Clients in the News – GW Researcher Awarded $2M to Study Natural Immune Response to HIV

A research team at the George Washington University (GW) School of Medicine and Health Sciences will study the body’s natural defenses against HIV and look for ways to eliminate the infectious HIV reservoirs in the white blood cells of people taking antiretroviral therapy. Millions of people, including children, live with HIV worldwide. The virus is […]

Clients in the News – OHSU Receives $15M for Pediatric Cancer Research Database

For life science researchers, having easy access to data and information is essential. They can use this data to research diseases and further personal research, benefiting other researchers and patients. Oregon Health and Science University in Portland recently received a five-year grant of $15 million from the National Institutes of Health to establish a first-of-its-kind […]

Clients in the News – Georgia State Discovering Photosynthesis Could Yield Novel Solar Cell Design

A phenomenon occurring in photosynthesis could help engineers create a new type of artificial solar cell. Researchers from Georgia State University explored a concept called “inverted-region electron transfer,” which could lead to new cells that could harness energy, such as hydrogen gas. The team analyzed the photosynthetic reaction centers found in the freshwater cyanobacterium species […]

Clients in the News – Novartis Receives Historic Approval for First Gene Therapy in the U.S.

The U.S. Food and Drug Administration (FDA) has approved tisagenlecleucel (Kymriah) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL). The historic action makes Novartis Pharmaceutical’s CAR-T cell treatment the first gene therapy available in the United States. (Gilead just negotiated to buy Kite Pharma, which also has a […]

Clients in the News – Univ. Chicago designs tiny nanopackages built out of DNA helping demonstrate how neurons work

A team of scientists from the University of Chicago designed a way to use microscopic capsules made out of DNA to deliver a payload of tiny molecules directly into a cell. The technique, detailed Aug. 21 in Nature Nanotechnology, gives scientists an opportunity to understand certain interactions among cells that have previously been hard to […]

Clients in the News – Univ. of Cincinnati Find Panic Disorder Symptoms May Be Tied to Acid-Sensing Receptor

Panic disorder is a syndrome characterized by spontaneous and recurrent episodes of incapacitating anxiety. It typically emerges during adolescence or early adulthood and can take an exhausting emotional and physical toll on the body. Physical symptoms can include heart palpitations, sweating and/or chills, trouble breathing and dizziness, nausea and even chest pain. While significant progress […]

Clients in the News – UCLA Increasing Cannabis Research With Newly Established Research Group

As cannabis use becomes legal in more and more states in the US, both for recreational and medical purposes, it is becoming necessary for more research into the drug. Currently in the US, 20% of the population have access to legal recreational marijuana use and 60% have access to legal medical marijuana. Unfortunately, even with […]

Clients in the News – UAB Cancer Research Center receives $14.5M in NCI Funding This Year

Last year, the University of Alabama at Birmingham Comprehensive Cancer Center was awarded a five-year, $29 million grant for the National Cancer Institute. The Cancer Center now receives nearly $6M a year in NCI core funding and will continue to do so through 2021. In addition to this core grant, UAB CCC has received over […]

Clients in the News – Frost & Sullivan Awards Akonni Biosystems for its Molecular Diagnostics Platform


Based on its recent analysis of microarrays in molecular diagnostics (MDx), Frost & Sullivan recognizes Akonni Biosystems, Inc. with the 2017 North America Frost & Sullivan Award for New Product Innovation. Akonni’s integrated MDx system, TruDiagnosis®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis® is […]

Clients in the News – Akonni Biosystems Wins NIH SBIR Grant for Pediatric Respiratory Disease Diagnostics


Akonni Biosystems said today that it has received a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop molecular diagnostic tests for lower respiratory diseases in children. The award, worth $225,000 and administered by the National Institute of Allergy and Infectious Diseases, is specifically intended to support the development […]

Clients in the News – AstraZeneca, Merck & Co. in $8.5-Billion Oncology Collaboration

AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s Lynparza (olaparib) for multiple cancer types. Lynparza is an oral poly ADP ribose polymerase (PARP) inhibitor for treating BRCA-mutated ovarian cancer in multiple lines of treatment. It was approved by FDA […]

Clients in the News – Immunomic Therapeutics Celebrates National Immunization Awareness Month

August is National Immunization Awareness Month and Rockville, MD based Immunomic is dedicated to raising awareness of the importance of receiving life-saving vaccines. Vaccines are recommended to people of all ages. Currently, vaccines protect against 26 diseases and remain the best defense against several serious diseases like measles and diphtheria. August is an ideal time […]

Clients in the News – Integrated BioTherapeutics Receives $6.6M Grant from NIAID

Integrated BioTherapeutics Inc., a Rockville, Md.-based a biotechnology company focused on the discovery of novel vaccines and therapies for emerging infectious diseases, has been awarded a $6.6m grant from the National Institute of Allergy and Infectious Diseases (NIAID). The funds will be used to develop a vaccine that can protect against all ebolaviruses. The research […]

Clients in the News – UBC: Ancient Fungi Could Help Canada’s Future Northern Forests

From Lab Manager Magazine article: As Canada’s vast boreal and tundra ecosystems experience dramatic warming due to climate change, trees are rapidly spreading north. New research from the University of British Columbia’s (UBC’s) Okanagan Campus suggests some of these trees could be getting help from a surprising source: fungi that have lain dormant underground for […]

Clients in the News – RoosterBio Launches the Regenerative Medicine Industry’s First Xeno-Free hMSC Cell Banks to Advance and Simplify Stem Cell Biomanufacturing

At a CAGR of 23.2% and estimated revenue of $68B by 2020, the Regenerative Medicine (“RM”) industry continues to call for new tools designed to accelerate this aggressive growth. Based on strong RM market demand, RoosterBio Inc today announces the launch of xeno-free (“XF”) human bone-marrow derived mesenchymal stem/stromal cell (hMSC) products. The RoosterVial™-XF line […]

Clients in the News – UMinn, 3D-bioprinted Patch Helps Heal Scarred Heart Tissue After Heart Attack

  When a person experiences a heart attack, blood flow to the heart muscle is lost and cells die. Since these heart muscle cells cannot be replaced, scar tissue forms in the heart, putting patients at risk for future heart failure or faulty heart function. Now, biomedical engineers from the University of Minnesota have created […]

Clients in the News – UCONN Researchers find Chili Pepper and Marijuana Calm the Gut

You wouldn’t think chili peppers and marijuana have much in common. But when eaten, both interact with the same receptor in our stomachs, according to a paper by UConn researchers published in the April 24 issue of the journal Proceedings of the National Academy of Sciences. The research could lead to new therapies for diabetes […]

Clients in the News – Saint Louis Univ. Scientists Take Aim at Diabetes, Obesity with Exercise in a Pill

  With a series of new grants, Saint Louis University researchers will tackle the twin epidemics of diabetes and obesity by tapping into the potential of two nuclear receptors that control muscle metabolism. The scientists will optimize two promising drug compounds, moving a step closer toward capturing the benefits of exercise in pill form. Thomas […]

Clients in the News – Baylor College and NIH: US Enrolls Volunteers in Large Test of Possible Zika Vaccine

U.S. health officials have begun enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women. The first volunteer was vaccinated Wednesday at Baylor College of Medicine in Houston, as the National Institutes of Health gears up for a two-part […]